Asset Details
Do you wish to reserve the book?
Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review
Do you wish to request the book?
Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cyanobacterial metabolites as novel drug candidates in corona viral therapies: A review
2022
Overview
Most of the medical and nonmedical research labs, all around the world, are racing against time to produce an effective vaccine or an antiviral medicine for coronavirus disease 2019 (COVID‐19). Conventional medicines and novel nano‐materials including chemical and herbal‐based compounds are all into positive trials toward coronaviruses and other pandemic infections. Among them, natural immune boosters have attracted physicians because of their longevity and reliability for fewer side effects. This is a review article with a detailed picture of an unexplored antiviral source with maximum potency in curing viral infections. Cyanobacteriae have been known for centuries and are rich in secondary metabolites of proteins, biopeptides, and polysaccharides for prominent antiviral action against chest infections. But detailed exploratory research is required to purify, scale‐up, and commercialize the pharmacologically active agents from these drug reserves.
Publisher
John Wiley & Sons, Inc,Department of Botany, Annai Vailankanni Arts and Science College, Thanjavur, Tamil Nadu, India%Department of Botany, A.V.V.M Sri Pushpam College, Poondi (Affiliated to Bharathidasan University), Thanjavur, Tamil Nadu, India%Department of Nanotechnology, Noorul Islam Centre for Higher Education, Kumaracoil, Tamil Nadu, India,John Wiley and Sons Inc,Wiley
Subject
